Subject: Fwd: ***New WHO Interim Guidance on COVID-19 Clinical Management***
From: Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To: info </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=2069f7f4886b493dbd84f07150d67a52-info>; Ekaterine Adamia </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=89b4d31758d34f2cbdcfe688199f6941-Ekateri>; Alisa Tsuladze </o=ExchOrganization/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=6c6cfa06d9a74264a5aa512b6bc62306-Alisa T>
Date: Thu, 21 May 2020 19:01:49 +0000

გთხოვთ დაარეგისტრიროთ

Sent from my Samsung Galaxy smartphone.

-------- Original message --------

From: "LYDON, Patrick" <[email-masked]>

Date: 5/21/20 10:51 PM (GMT+04:00)

To: solidaritytrials <[email-masked]>

Cc: "SWAMINATHAN, Soumya" <[email-masked]>, "HENAO RESTREPO, Ana Maria" <[email-masked]>, "PREZIOSI, Marie-pierre" <[email-masked]>, "SATHIYAMOORTHY, Vaseeharan" <[email-masked]>, "DARA, Masoud" <[email-masked]>, "OKEIBUNOR, Joseph Chukwudi"
<[email-masked]>, "Reveiz, Dr. Ludovic (WDC)" <[email-masked]>, Maria Consuelo <[email-masked]>, "KODAMA, Chiori" <[email-masked]>, "AZIM, Tasnim" <[email-masked]>, "ESCALANTE, Socorro" <[email-masked]>

Subject: ***New WHO Interim Guidance on COVID-19 Clinical Management***

Dear Solidarity Trial P.Is and esteemed colleagues,

We are pleased to be sharing with you the new WHO ‘interim’ guidance on COVID-19 clinical management (attached). This is a key documents in our
collective objective to: (1) Slow and stop transmission of the virus; (2) Provide optimized care for all patients; and (3) Minimize the impact of the epidemic on health systems, social services and economic activity.

This guidance is intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. As all of you copied are involved
in the Solidarity Trial, we wanted to make sure you get this document and we encourage you to share this broadly within your networks. Please note that it is not meant to replace clinical judgment or specialist consultation, but rather to strengthen frontline
clinical management based on the latest WHO guidance.

Furthermore, we wanted to thank you for all your hard work, dedication and time with enrolling patients in Solidarity Trial. To date,
17 countries have started Solidarity Trial in
320 hospitals around the world and where
885 clinicians including yourselves are involved. Patient enrollment has surpassed
3,000 on May 18th – 8 weeks since the launch of the initiative on March 18 by the Director General of the WHO (Dr. Tedros). By the end of May, we expect another
10-12 countries to start enrolling patients with at least one country representing each WHO region. This is tremendous progress and we owe it to you. You should all be proud to be part of this global mega-trial
to help research into an effective COVID-19 treatment and your efforts are not going unnoticed.

Of course, the battle against this pandemic is far from over and time is not on our side. The faster we can go, the quicker we can
identify solutions. The international community is counting on your help to implement and accelerate all possible efforts for Solidarity Trial and to enroll as many patients as possible.

All the very best and keep safe.

Patrick

(on behalf of Dr Soumya (WHO Chief Scientist); the co-leads of Solidarity
Trial (Dr Ana Maria, Dr Marie-Pierre and Dr Vasee); and our Regional and Country Office Focal points that have done an incredible job helping)

___________________________________________________________________________

Patrick Lydon

Research & Development Blueprint Unit
–
WHO Health Emergencies Preparedness & Response

World Health Organization | 20 Avenue Appia | CH-1211 Geneva 27 Switzerland | Office: M1156

*:
[email-masked]
|(:office
+41.22.791.4238 |(:mobile
+41.79.475.5550 |(:skype:
patricklydon

Promote health, keep the world safe, and serve the vulnerable